BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23947816)

  • 1. Formation and physicochemical properties of crystalline and amorphous salts with different stoichiometries formed between ciprofloxacin and succinic acid.
    Paluch KJ; McCabe T; Müller-Bunz H; Corrigan OI; Healy AM; Tajber L
    Mol Pharm; 2013 Oct; 10(10):3640-54. PubMed ID: 23947816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmaceutical salts of ciprofloxacin with dicarboxylic acids.
    Surov AO; Manin AN; Voronin AP; Drozd KV; Simagina AA; Churakov AV; Perlovich GL
    Eur J Pharm Sci; 2015 Sep; 77():112-21. PubMed ID: 26066411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of amorphous ciprofloxacin-amino acid salts.
    Mesallati H; Conroy D; Hudson S; Tajber L
    Eur J Pharm Biopharm; 2017 Dec; 121():73-89. PubMed ID: 28919470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymer/Amorphous Salt Solid Dispersions of Ciprofloxacin.
    Mesallati H; Tajber L
    Pharm Res; 2017 Nov; 34(11):2425-2439. PubMed ID: 28875408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
    Dichiarante E; Curzi M; Giaffreda SL; Grepioni F; Maini L; Braga D
    J Pharm Pharmacol; 2015 Jun; 67(6):823-9. PubMed ID: 25644936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and Physiochemical Analysis of Novel Ciprofloxacin / Dicarboxylic Acid Salts.
    Hibbard T; Nyambura B; Scholes P; Totolici M; Shankland K; Al-Obaidi H
    J Pharm Sci; 2023 Jan; 112(1):195-203. PubMed ID: 35948159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of counterions on the properties of amorphous atorvastatin salts.
    Sonje VM; Kumar L; Puri V; Kohli G; Kaushal AM; Bansal AK
    Eur J Pharm Sci; 2011 Nov; 44(4):462-70. PubMed ID: 21907794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the solubility and solid-state properties of saccharin salts of fluoroquinolones.
    Romañuk CB; Manzo RH; Linck YG; Chattah AK; Monti GA; Olivera ME
    J Pharm Sci; 2009 Oct; 98(10):3788-801. PubMed ID: 19226631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine.
    Kasten G; Nouri K; Grohganz H; Rades T; Löbmann K
    Int J Pharm; 2017 Nov; 533(1):138-144. PubMed ID: 28947246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salt and cocrystals of sildenafil with dicarboxylic acids: solubility and pharmacokinetic advantage of the glutarate salt.
    Sanphui P; Tothadi S; Ganguly S; Desiraju GR
    Mol Pharm; 2013 Dec; 10(12):4687-97. PubMed ID: 24168322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amorphous Polymeric Drug Salts as Ionic Solid Dispersion Forms of Ciprofloxacin.
    Mesallati H; Umerska A; Paluch KJ; Tajber L
    Mol Pharm; 2017 Jul; 14(7):2209-2223. PubMed ID: 28570079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular salts and co-crystals of mirtazapine with promising physicochemical properties.
    Sarkar A; Rohani S
    J Pharm Biomed Anal; 2015 Jun; 110():93-9. PubMed ID: 25818704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterisation of novel chlorothiazide potassium solid-state salt forms: Intermolecular self assembly suprastructures.
    Paluch KJ; Tajber L; McCabe T; O'Brien JE; Corrigan OI; Healy AM
    Eur J Pharm Sci; 2011 Feb; 42(3):220-9. PubMed ID: 21115114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and properties of domperidone and its succinate salt.
    Bruni G; Maietta M; Scotti F; Maggi L; Bini M; Ferrari S; Capsoni D; Boiocchi M; Berbenni V; Milanese C; Girella A; Marini A
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2013 Aug; 69(Pt 4):362-70. PubMed ID: 23873061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supramolecular structures and physicochemical properties of norfloxacin salts.
    Xu Y; Jiang L; Mei X
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2014 Aug; 70(Pt 4):750-60. PubMed ID: 25080254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallographic, thermal and spectroscopic characterization of a ciprofloxacin saccharinate polymorph.
    Romañuk CB; Garro Linck Y; Chattah AK; Monti GA; Cuffini SL; Garland MT; Baggio R; Manzo RH; Olivera ME
    Int J Pharm; 2010 May; 391(1-2):197-202. PubMed ID: 20214961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolone salts with carboxylic acids.
    Reddy JS; Ganesh SV; Nagalapalli R; Dandela R; Solomon KA; Kumar KA; Goud NR; Nangia A
    J Pharm Sci; 2011 Aug; 100(8):3160-3176. PubMed ID: 21394722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical characterization of nedocromil bivalent metal salt hydrates. 2. Nedocromil zinc.
    Zhu H; Padden BE; Munson EJ; Grant DJ
    J Pharm Sci; 1997 Apr; 86(4):418-29. PubMed ID: 9109042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and evaluation of metastable solid-state forms of lopinavir.
    Lemmer HJ; Liebenberg W
    Pharmazie; 2013 May; 68(5):327-32. PubMed ID: 23802429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.